Glycan’s in Vaccine Development
5
Glycan’s are at the centre of many disorders and diseases igniting the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycan’s are intricately involved. Determining the entire capacity and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.
Related Conference of Glycan’s in Vaccine Development
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
Glycan’s in Vaccine Development Conference Speakers
Recommended Sessions
- Glycobiology in Lipid Science
- Glycans in Structural and Computational Systems Biology
- Genomics and Metabolomics
- Glycan’s in Vaccine Development
- Glycans in Diseases and Therapeutics
- Glycobiology and Glycochemistry
- Glycochemistry
- Glycoconjugates, Glycomics and Transcriptomics
- Glycosciences and Monosaccharides
- Structural Bioinformatics and Proteomics